Literature DB >> 2958962

Mycobacterium avium-complex infections in normal and immunodeficient mice.

F M Collins1, R W Stokes.   

Abstract

Specific pathogen-free C57Bl/6 X DBA/2 (B6D2) F1 hybrid mice were challenged aerogenically with M. avium, M. intracellulare and M. scrofulaceum and the resulting lung and spleen infections were followed over a period of several months. Growth of the mouse virulent M. avium 724 and M. intracellulare D673 was more extensive in the susceptible (Balb/c or C57Bl/6) mice than it was in the resistant A/J and B6D2 strains. Oral challenge of normal C57Bl/6 mice with virulent M. avium-complex serotypes resulted in substantial infection of the gut-associated lymphoid tissues, the lungs and spleen. No infection developed when the mice were infected orally with the avirulent MAC serotypes. T-cell depleted Balb/c (nude or Thxb) mice infected with virulent M. avium developed markedly enhanced lung and spleen infections compared to those seen in the immunocompetent controls. T-cell depletion did not potentiate the systemic growth of the avirulent MAC strains. The significance of these growth patterns (especially in the T-cell depleted mouse) is discussed in relation to the development of life-threatening M. avium-complex infections in patients with Acquired Immune Deficiency Syndrome.

Entities:  

Mesh:

Year:  1987        PMID: 2958962     DOI: 10.1016/0041-3879(87)90028-6

Source DB:  PubMed          Journal:  Tubercle        ISSN: 0041-3879


  16 in total

1.  Reduced numbers of CD4+ suppressor cells with subsequent expansion of CD8+ protective T cells as an explanation for the paradoxical state of enhanced resistance to Leishmania in T-cell deficient BALB/c mice.

Authors:  J O Hill
Journal:  Immunology       Date:  1991-02       Impact factor: 7.397

Review 2.  Immunobiology of Mycobacterium avium infection.

Authors:  L E Bermudez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

3.  T-cell immune responses in Mycobacterium avium-infected mice.

Authors:  R D Hubbard; C M Flory; F M Collins
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

Review 4.  AIDS-related mycobacterial disease.

Authors:  F M Collins
Journal:  Springer Semin Immunopathol       Date:  1988

5.  Characterization of mouse models of Mycobacterium avium complex infection and evaluation of drug combinations.

Authors:  Claire Andréjak; Deepak V Almeida; Sandeep Tyagi; Paul J Converse; Nicole C Ammerman; Jacques H Grosset
Journal:  Antimicrob Agents Chemother       Date:  2015-01-26       Impact factor: 5.191

6.  Comparative activities of amikacin against Mycobacterium avium complex in nude and beige mice.

Authors:  N Lounis; B Ji; C Truffot-Pernot; J Grosset
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

Review 7.  The Mycobacterium avium complex.

Authors:  C B Inderlied; C A Kemper; L E Bermudez
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

8.  Biologically distinct subtypes of Mycobacterium avium differ in possession of insertion sequence IS901.

Authors:  Z M Kunze; F Portaels; J J McFadden
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

9.  Improving existing tools for Mycobacterium xenopi treatment: assessment of drug combinations and characterization of mouse models of infection and chemotherapy.

Authors:  Claire Andréjak; Deepak V Almeida; Sandeep Tyagi; Paul J Converse; Nicole C Ammerman; Jacques H Grosset
Journal:  J Antimicrob Chemother       Date:  2012-11-05       Impact factor: 5.790

10.  Mycobacterium avium complex infection in mice: lack of exacerbation after LP-BM5 murine leukemia virus infection.

Authors:  F Grassi; C Perronne; M Levacher-Clergeot; Y Cohen; C Maslo; F Chau; M Sinet; J J Pocidalo
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.